Clinical trial
Mechanism of NK Cell Disfunction in Graves' Disease
NCT04135573 is registered in ClinicalTrials.gov with Shandong Provincial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanism of NK Cell Disfunction in Graves' Disease
- Lead sponsor
- Shandong Provincial Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 15, 2018
- Completion date
- June 30, 2022
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.